Cargando…
Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
INTRODUCTION: Available literature suggests that the advantage of animal-derived surfactants over first-generation synthetic agents derives from the presence of surface-active proteins and their phospholipid content. Here we summarize the results of clinical trials comparing animal-derived surfactan...
Autores principales: | Logan, J Wells, Moya, Fernando R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697515/ https://www.ncbi.nlm.nih.gov/pubmed/19436610 |
Ejemplares similares
-
Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023) -
The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012) -
Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment
por: Özkan, Hasan, et al.
Publicado: (2018) -
History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019) -
Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022)